» Articles » PMID: 35745168

The Role of Obesity, Inflammation and Sphingolipids in the Development of an Abdominal Aortic Aneurysm

Overview
Journal Nutrients
Date 2022 Jun 24
PMID 35745168
Authors
Affiliations
Soon will be listed here.
Abstract

Abdominal aortic aneurysm (AAA) is a local dilatation of the vessel equal to or exceeding 3 cm. It is a disease with a long preclinical period commonly without any symptoms in its initial stage. Undiagnosed for years, aneurysm often leads to death due to vessel rupture. The basis of AAA pathogenesis is inflammation, which is often associated with the excess of adipose tissue, especially perivascular adipose tissue, which synthesizes adipocytokines that exert a significant influence on the formation of aneurysms. Pro-inflammatory cytokines such as resistin, leptin, and TNFα have been shown to induce changes leading to the formation of aneurysms, while adiponectin is the only known compound that is secreted by adipose tissue and limits the development of aneurysms. However, in obesity, adiponectin levels decline. Moreover, inflammation is associated with an increase in the amount of macrophages infiltrating adipose tissue, which are the source of matrix metalloproteinases (MMP) involved in the degradation of the extracellular matrix, which are an important factor in the formation of aneurysms. In addition, an excess of body fat is associated with altered sphingolipid metabolism. It has been shown that among sphingolipids, there are compounds that play an opposite role in the cell: ceramide is a pro-apoptotic compound that mediates the development of inflammation, while sphingosine-1-phosphate exerts pro-proliferative and anti-inflammatory effects. It has been shown that the increase in the level of ceramide is associated with a decrease in the concentration of adiponectin, an increase in the concentration of TNFα, MMP-9 and reactive oxygen species (which contribute to the apoptosis of vascular smooth muscle cell). The available data indicate a potential relationship between obesity, inflammation and disturbed sphingolipid metabolism with the formation of aneurysms; therefore, the aim of this study was to systematize the current knowledge on the role of these factors in the pathogenesis of abdominal aortic aneurysm.

Citing Articles

CIDEC/FSP27 exacerbates obesity-related abdominal aortic aneurysm by promoting perivascular adipose tissue inflammation.

Zhu Q, Luo D, Li Y, Yu L, Zhang Z, Ouyang F Life Metab. 2025; 4(1):loae035.

PMID: 39872985 PMC: 11770823. DOI: 10.1093/lifemeta/loae035.


Identification of serum biomarkers and therapeutic targets for aortic diseases in obesity through multi-omics analysis.

Wang T, Wang Y, Wang Y, Wang X, Cheng X, Tan Q J Thorac Dis. 2025; 16(12):8435-8449.

PMID: 39831259 PMC: 11740044. DOI: 10.21037/jtd-24-1113.


Identification of CCR7 and CBX6 as key biomarkers in abdominal aortic aneurysm: Insights from multi-omics data and machine learning analysis.

Yong X, Hu X, Kang T, Deng Y, Li S, Yu S IET Syst Biol. 2024; 18(6):250-260.

PMID: 39602349 PMC: 11665846. DOI: 10.1049/syb2.12106.


Feature genes identification and immune infiltration assessment in abdominal aortic aneurysm using WGCNA and machine learning algorithms.

Xie M, Li X, Qi C, Zhang Y, Li G, Xue Y Front Cardiovasc Med. 2024; 11:1497170.

PMID: 39600608 PMC: 11588672. DOI: 10.3389/fcvm.2024.1497170.


Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?.

Foran D, Antoniades C, Akoumianakis I Nutrients. 2024; 16(19).

PMID: 39408263 PMC: 11478599. DOI: 10.3390/nu16193296.


References
1.
Payne S, Milstien S, Spiegel S . Sphingosine-1-phosphate: dual messenger functions. FEBS Lett. 2002; 531(1):54-7. DOI: 10.1016/s0014-5793(02)03480-4. View

2.
Herz J, Kowal R, Goldstein J, Brown M . Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 1990; 9(6):1769-76. PMC: 551881. DOI: 10.1002/j.1460-2075.1990.tb08301.x. View

3.
Police S, Thatcher S, Charnigo R, Daugherty A, Cassis L . Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2009; 29(10):1458-64. PMC: 2753598. DOI: 10.1161/ATVBAHA.109.192658. View

4.
Nodai A, Machida T, Izumi S, Hamaya Y, Kohno T, Igarashi Y . Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci. 2007; 80(19):1768-76. DOI: 10.1016/j.lfs.2007.02.008. View

5.
Keul P, Sattler K, Levkau B . HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev. 2007; 12(3-4):301-6. DOI: 10.1007/s10741-007-9038-x. View